# A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury

> **NCT06841770** · PHASE1 · RECRUITING · sponsor: **Lineage Cell Therapeutics, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Spinal Cord Injury Cervical
- Spinal Cord Injury Thoracic
- Spinal Cord Injury, Acute
- Spinal Cord Injury
- Spinal Cord Injury, Chronic

## Interventions

- **BIOLOGICAL:** OPC1

## Key facts

- **NCT ID:** NCT06841770
- **Lead sponsor:** Lineage Cell Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2027-08-10
- **Final completion:** 2037-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06841770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06841770, "A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06841770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*